Aprepitant/Fosaprepitant Dimeglumine and Omadacycline Tablets
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Omadacycline Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Omadacycline Tosylate
- Aprepitant/Fosaprepitant Dimeglumine-Omalizumab
- Aprepitant/Fosaprepitant Dimeglumine-Omalizumab Subcutaneous
- Aprepitant/Fosaprepitant Dimeglumine-Ombitasvir, Paritaprevir, and Ritonavir
- Aprepitant/Fosaprepitant Dimeglumine-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Aprepitant/Fosaprepitant Dimeglumine-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Omadacycline Tablets-Apresazide
- Omadacycline Tablets-Apresoline
- Omadacycline Tablets-Apresoline Injection
- Omadacycline Tablets-Apri
- Omadacycline Tablets-Apriso
- Omadacycline Tablets-Aprizio Pak